VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $13,000 | -87.0% | 550 | -91.3% | 0.01% | -82.8% |
| Q1 2018 | $100,000 | -23.7% | 6,300 | 0.0% | 0.03% | -23.7% |
| Q4 2017 | $131,000 | +107.9% | 6,300 | +43.2% | 0.04% | +81.0% |
| Q3 2017 | $63,000 | -8.7% | 4,400 | +10.0% | 0.02% | -16.0% |
| Q2 2017 | $69,000 | +50.0% | 4,000 | +1042.9% | 0.02% | +8.7% |
| Q3 2014 | $46,000 | +4.5% | 350 | 0.0% | 0.02% | +9.5% |
| Q2 2014 | $44,000 | -4.3% | 350 | 0.0% | 0.02% | +40.0% |
| Q1 2014 | $46,000 | – | 350 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |